Back
Akoya Biosciences Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
54
AKYA
Akoya Biosciences
Last Price:
3.09
Seasonality Move:
7.62%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Akoya Biosciences Price Quote
$3.09
Akoya Biosciences Key Stats
Buy
54
Akoya Biosciences (AKYA)
is a Buy
Day range:
$2.60 - $3.10
52-week range:
$1.88 - $6.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.63
P/B ratio:
6.87%
Volume:
149.4K
Avg. volume:
118.5K
1-year change:
-21.97%
Market cap:
$153M
Revenue:
$96.6M
EPS:
$-1.23
How Much Does Akoya Biosciences Make?
-
How Much Are Akoya Biosciences's Sales Annually?
AKYA Revenues are $96.6M -
How Much Profit Does Akoya Biosciences's Make A Year?
AKYA net income is -$63.3M
Is Akoya Biosciences Growing As A Company?
-
What Is Akoya Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.02% -
What Is Akoya Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Akoya Biosciences Stock Price Performance
-
Did Akoya Biosciences Stock Go Up Last Month?
Akoya Biosciences share price went up by 11.15% last month -
Did AKYA's Share Price Rise Over The Last Year?
AKYA share price fell by -21.97% over the past 1 year
What Is Akoya Biosciences 52-Week High & Low?
-
What Is Akoya Biosciences’s 52-Week High Share Price?
Akoya Biosciences has traded as high as $6.31 over the past 52 weeks -
What Is Akoya Biosciences’s 52-Week Low Share Price?
Akoya Biosciences has traded as low as $1.88 over the past 52 weeks
Akoya Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akoya Biosciences?
-
How Much Debt Does Akoya Biosciences Have?
Total long term debt quarterly is $75.7M -
How Much Cash Does Akoya Biosciences Have?
Cash and short term investments quarterly total is $45.2M -
What Is Akoya Biosciences’s Book Value Per Share?
Book value per share is 0.45
Is Akoya Biosciences Cash Flow Positive?
-
What Is AKYA Cash Flow From Operations?
Cash flow from operations (TTM) is -$51.2M -
What Is Akoya Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $8.4M -
What Is Akoya Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$41.2M
Akoya Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
AKYA return on invested capital is -50.59% -
What Is Akoya Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -35.71% -
What Is AKYA Return On Equity?
ROE is a measure of profitability and is -124.38%
Akoya Biosciences Earnings Date & Stock Price
-
What Is Akoya Biosciences's Stock Price Today?
A single share of AKYA can be purchased today for 3.09 -
What Is Akoya Biosciences’s Stock Symbol?
Akoya Biosciences trades on the nasdaq under the ticker symbol: AKYA -
When Is Akoya Biosciences’s Next Earnings Date?
The next quarterly earnings date for Akoya Biosciences is scheduled on November 14, 2024 -
When Is AKYA's next ex-dividend date?
Akoya Biosciences's next ex-dividend date is November 6, 2024 -
How To Buy Akoya Biosciences Stock?
You can buy Akoya Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akoya Biosciences Competitors
-
Who Are Akoya Biosciences's Competitors?
Below is a list of companies who compete with Akoya Biosciences or are related in some way:
Akoya Biosciences Dividend Yield
-
What Is AKYA Dividend Yield?
Akoya Biosciences’s dividend yield currently is 0% -
What Is Akoya Biosciences’s Payout Ratio?
Akoya Biosciences’s payout ratio is 0% -
When Did Akoya Biosciences Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Akoya Biosciences’s Dividend Per Share?
Akoya Biosciences pays a dividend of $0.00 per share
Akoya Biosciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 1.59% |
| Revenue: | -1.52% | -1.65% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 4.80 |
| Upside from Last Price: | 55.34% |